Skip to the content
  • Our Company
    • Management Team
    • Board Members
    • Events
  • Our Approach
  • Partner
  • Careers
  • Resources
  • News
Menu
  • Our Company
    • Management Team
    • Board Members
    • Events
  • Our Approach
  • Partner
  • Careers
  • Resources
  • News
  • Contact
Menu
  • Contact

Nimble supported collaboration with Roche featured in Nature Communications focus on translational and clinical research.

read more
Path 3
  • Scientific Publication
  • January 26, 2021

Nimble’s collaboration with Roche, recently published in Nature Communications as “Protease-activation using anti-idiotypic masks enables tumor specificity of a folate receptor 1-T cell bispecific antibody” has been featured in a focus on translational and clinical research. A link to the articles featured as well as the publication can be found below:

Featured Articles: https://www.nature.com/collections/ecgchegdhe

Publication: https://www.nature.com/articles/s41467-020-16838-w

PreviousBiomarker Research by Nimble Scientists Featured in The Rheumatologist
NextIntroduction
PreviousBiomarker Research by Nimble Scientists Featured in The Rheumatologist
NextIntroduction
  • Our Company
  • Our Approach
  • Partner
  • Careers
  • Resources
  • Contact
  • Our Company
  • Our Approach
  • Partner
  • Careers
  • Resources
  • Contact
  • Our Company
  • Our Approach
  • Partner
  • Careers
  • Resources
  • Contact
  • Our Company
  • Our Approach
  • Partner
  • Careers
  • Resources
  • Contact

603 Science Dr
Madison, WI, USA 53711

LinkedIn
  • Nimble Therapeutics Announces Expansion of its Discovery and Development Partnership with Genentech
    Read More